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INTRODUCTION
The prevalence of peripheral arterial disease (PAD) 
ranges from 3% to 10% worldwide and has been in-
creasing due to progressive growth in the older pop-
ulation, changes in dietary habits, and the increasing 
incidence of diabetes.1,2 PAD is often associated with 
other critical arteriosclerotic diseases, such as coronary 
artery disease (CAD) or cerebrovascular disease (CVD). 
High prevalence of CAD in PAD patients has been re-
ported previously.3,4 This pathologic state is the main 
cause of death in patients with critical limb ischemia 
(CLI).5 Most patients with advanced CLI already exhib-
it dermatologic ulcerative lesions that require surgical 
management; these lesions are classified as “Rutherford 
grade 5.6”6 and have a high risk of complications ac-
companying critical arteriosclerotic diseases. Severity of 
PAD is supposed to be associated with severity of sys-
temic arteriosclerotic state and prevalence of CAD. We 
must conduct careful perioperative management in pa-
tients with severe PAD. However, only a few reports have 
addressed the prevalence of CAD and CVD of patients 
with CLI who underwent surgical management, with 
little evidence of correlation between PAD severity and 
prevalence of CAD.
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Background: Due to the increase of elderly and diabetes patients, surgeons encoun-
ter patients requiring treatment of critical limb ischemia (CLI) in the presence of 
systemic arteriosclerotic diseases. In this study, we retrospectively investigated the 
prevalence of coronary artery disease (CAD) in patients with CLI who underwent 
major (above-the-ankle) amputation or nonmajor amputation (below-the-ankle 
amputation or debridement of wound).
Methods: We retrospectively investigated 129 consecutive patients surgically managed 
for CLI in our institution between January 2013 and December 2015. The prevalence 
of CAD was defined as a cardiac treatment history or significant vascular stenosis (ste-
nosis of > 75%). The outcomes were compared between patients who underwent ma-
jor amputation (n = 36) and nonmajor amputation (n = 93). Additionally, archived 
record of 566 patients treated nonsurgically by percutaneous transluminal angioplasty 
in our institution was investigated to evaluate patients with milder peripheral artery 
disease.
Results: CAD was present in 83 patients (69%), including 82% of patients who 
underwent major amputation and 63% of nonmajor amputation group. The 
prevalence of CAD was significantly higher in the major amputation group 
(P = 0.042). Ejection fraction was not significantly different (P > 0.05). Among 
the 566 CLI patients treated by only percutaneous transluminal angioplasty, 227 
(40%) had CAD, which was a significantly lower prevalence than those surgically 
treated (P < 0.001).
Conclusions: The presence of CAD is more frequent in CLI patients who re-
quire extended surgical management of the limb than in those who do not. 
Evaluation of CAD and careful perioperative management are important for pa-
tients with CLI patients. (Plast Reconstr Surg Glob Open 2017;5:e1377; doi: 10.1097/
GOX.0000000000001377; Published online 28 June 2017.)
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In our institution, the vascular circulation of almost 
all patients with CLI is examined preoperatively using 
cardiac ultrasonography and/or cardiac angiography. We 
hypothesized that patients who have undergone major 
amputation have a higher prevalence rate of CAD than 
do patients who have undergone minor amputation or 
surgical debridement. The purpose of this retrospective 
study was to compare the prevalence of CAD in patients 
with CLI who underwent lower limb amputation, debride-
ment of the limb wound, or percutaneous transluminal 
angioplasty (PTA).
METHODS
Study Population
This study followed the principles outlined in the Dec-
laration of Helsinki and was approved by the Institutional 
Ethics Committee of our hospital. Retrospective analyses 
were performed on a consecutive series of 129 patients 
with CLI who were surgically managed from January 2013 
to December 2015 in our institution. Cardiac ultrasonog-
raphy or angiography was performed before the surgi-
cal treatment. The patients were classified into 2 groups: 
major amputation group (above-the-ankle amputation, 
n = 36) and nonmajor amputation (below-the-ankle am-
putation or debridement of the wound, n = 93). We inves-
tigated age, sex, clinical history, smoking habit, follow-up 
period, and the prevalence of CAD and/or CVD. Addition-
ally, we evaluated the prevalence of CAD and/or CVD in 
566 patients with PAD who underwent PTA without surgi-
cal treatment in our institution to evaluate patients with 
milder PAD.
Study Endpoints and Definitions
The primary endpoint of our study was to analyze the 
prevalence of CAD in our CLI patients. The presence 
of CAD was defined as a cardiac treatment history or 
significant vascular stenosis (stenosis of > 75%). A car-
diac treatment history was defined as receiving medica-
tion for symptoms of myocardial ischemia, such as oral 
or sublingual nitrates, or having a history of percuta-
neous coronary intervention or coronary artery bypass 
grafting. Presence of CVD wad defined as experiencing 
episodes of cerebral hemorrhage or cerebral infarc-
tion. Major amputation was defined as amputation of 
the lower limb proximal to the ankle (above-the-ankle 
amputation), and nonmajor amputation was defined as 
either amputation of the lower limb distal to the ankle 
(below-the-ankle amputation) or surgical debridement 
of the wound.
Statistical Analysis
Continuous data are expressed as mean with SD, and 
categorical data are summarized as frequency (%). Group 
comparisons were performed using Student’s t test, the 
chi-square test, or Fisher’s exact test as appropriate. All 
statistical analyses were performed with SAS 9.4 (SAS In-
stitute, Cary, N.C.). A value of P < 0.05 was considered 
significant.
RESULTS
There were no significant differences between the 
major (n = 36) and nonmajor (n = 93) amputation 
groups in age, sex, smoking habit, or other investigation 
items as baseline characteristics (Table 1). The mean 
follow-up period from surgical intervention was 12.5 
months (range, 1–29 months) in the nonmajor amputa-
tion group and 14.8 months (range, 1–34 months) in the 
major amputation group, with no significant difference 
(P = 0.18).
Among the 129 CLI patients with surgical treatment, 
121 patients had undergone cardiac angiography or per-
cutaneous coronary intervention. CAD was present in 83 
of the 121 patients (69%), including 82% in the major 
amputation group (28 of 34 patients) and 63% in the 
nonmajor amputation group (55 of 87 patients), show-
ing a significantly higher prevalence rate of CAD in the 
major amputation group (P = 0.042; Table 1; Fig. 1). No 
significant difference was found in the cardiac ejection 
fraction between the 2 groups. Among the 566 patients 
with PAD who did not undergo surgical treatment for CLI 
but underwent PTA, 227 (40%) had CAD, which was a sig-
nificantly lower prevalence than those surgically treated 
(P < 0.001; Fig. 1).
DISCUSSION
The important outcome of this study was that the 
prevalence of CAD was significantly higher in the major 
than nonmajor amputation group. It appears that the risk 
of CAD was correlated with the severity of limb ischemia. 
Careful perioperative management is required for major 
amputation in CLI.
Cardiac function has been considered to have a marked 
impact on the prognosis of patients with CLI.7 In an epide-
miological investigation that was based on the internation-
al Reduction of Atherothrombosis for Continued Health 
(REACH) Registry involving 68,000 patients in 44 coun-
tries, including patients with atherothrombosis or with 
3 or more risk factors for atherothrombosis, there were 
7,013 patients with PAD with either CAD (53.6%), CVD 
(23.7%), or both CAD and CVD (14.2%).8 Furthermore, 
the Bypass and Endovascular therapy Against Critical limb 
ischemia from Hyogo (BEACH) Registry of the Japanese 
population of 459 patients with CLI after undergoing re-
vascularization (Rutherford grade 4–6) showed that the 
prevalence of CAD was 41.1%.9 As shown in Fig. 1, compar-
ison of the CAD prevalence among the above-mentioned 
published reports and our study indicates a significantly 
higher prevalence of CAD in our patients who underwent 
surgical intervention, especially in the major amputation 
group. Lee et al.10 reported that cardiac angiography ex-
amination of 252 patients with CLI showed severe CAD in 
57.5% of patients (stenosis of ≥ 70%), and their patients 
with CAD showed a mean ejection fraction of 53% ± 10%. 
Our patients had higher prevalence of CAD and lower 
mean ejection fraction (Table 1), suggesting that CAD 
is more severe in patients with CLI who require surgical 
management than in those for whom surgical manage-
ment can be avoided.
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The prevalence of CAD in the nonmajor amputa-
tion group was significantly higher than that in patients 
who did not undergo surgical treatment but PTA (P < 
0.001; Fig. 1). Therefore, even in patients treated by mi-
nor amputation or debridement for a localized lesion, 
careful perioperative management is considered neces-
sary with attention to signs of complications. Based on 
the findings of published articles and the present study, 
we consider that detailed cardiac evaluations including 
cardiac ultrasonography or angiography are necessary 
for patients with CLI in whom surgical management is 
to be performed. Cardiac examination data will mark-
edly help in selecting the order of treatment (conduct 
percutaneous coronary intervention or bypass surgery 
beforehand or not), appropriate anesthesia method 
(general anesthesia, lumbar anesthesia, nerve block, or 
Table 1. Baseline Characteristics and the Prevalence of Coronary Artery Disease and/or CVD in Patients with CLI
Variables All Patients (n = 129) With Major Amputation (n = 36) Without Major Amputation (n = 93) P*
Age (y), mean ± SD 74 ± 11 73 ± 12 74 ± 10 0.764
  > 75 57 (44) 16 (44) 41 (44) 0.971
Sex     
  Male 89 (69) 27 (75) 62 (67) 0.359
Smoking     
  No 42 (33) 11 (31) 31 (33) 0.828
  Previously yes 28 (22) 7 (19) 21 (23)  
  Currently yes 59 (46) 18 (50) 41 (44)  
BMI (kg/m2), mean ± SD 20.6 ± 4.3 20.1 ± 5.3 20.8 ± 3.8 0.396
Comorbidities, n (%)     
  Chronic kidney disease—yes 91 (71) 25 (69) 66 (71) 0.865
  Dialysis—yes 76 (59) 24 (67) 52 (56) 0.266
  Hypertension—yes 97 (75) 25 (69) 72 (77) 0.347
  Dyslipidemia—yes 58 (45) 16 (44) 42 (45) 0.941
  Diabetes—yes 92 (71) 27 (75) 65 (70) 0.565
Albumin (g/dL), mean ± SD 3.3 ± 0.7 3.2 ± 0.8 3.4 ± 0.6 0.056
HbA1c (%), mean ± SD 6.9 ± 1.8 6.6 ± 1.3 7.0 ± 1.9 0.187
Multiple drug-resistant bacteria 
present—yes
45 (35) 9 (25) 36 (39) 0.143
Variables All Patients (n = 121) With Major Amputation (n = 34) Without Major Amputation (n = 87) P*
CAD—yes 83 (69) 28 (82) 55 (63) 0.042
CVD—yes 43 (33) 10 (28) 33 (35) 0.405
EF (%), mean ± SD 49.4 ± 14.6 48.1 ± 15.8 49.9 ± 14.1 0.536
  < 50% 59 (46) 20 (56) 39 (42) 0.164
Eight of 129 patients with CLI with surgical treatment lack cardiac angiography data or percutaneous coronary intervention data. The prevalence of CAD and/or 
CVD was calculated in 121 patients. Data are presented as the mean ± SD or the number (%) unless otherwise indicated.
*Analyzed by Student’s t test for continuous data and by the χ2 test for categorical data.
BMI, body mass index; HbA1c, hemoglobin A1c; EF, ejection fraction.
Fig. 1. comparison of the prevalence of coronary artery disease. comparisons were done among sur-
gically managed patients (all patients, major amputation group, and nonmajor amputation group), 
nonsurgically managed PaD patients (Pta group), patients in the ReacH Registry, and patients in the 
BeacH Registry.
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local anesthesia), optimum surgical method, and periop-
erative management method. Lee et al.10 recommended 
a screening examination using cardiac angiography for 
patients with CLI. Of their 167 patients with CAD, 78.6% 
underwent percutaneous coronary intervention in their 
report. Collaboration between surgeons and cardiolo-
gists, including sharing detailed data on cardiac function 
and CAD, is considered necessary for management of pa-
tients with CLI because follow-up treatment may extend 
over a long period after invasive surgery to save lives and 
limbs.
This study has several limitations. First, this was a 
nonrandomized, single-center study with a relative-
ly small number of patients. Second, excluding the 
BEACH Registry data, differences exist among countries 
with respect to the definition of CAD, data collection 
timing, and patients’ Rutherford grades, as well as eth-
nic and life environments. Additionally, adjustment for 
background factors for a more accurate comparison was 
not possible because individual data of other research-
ers’ reports were not accessible. A multi-institutional 
study involving a larger number of patients is therefore 
desired to confirm whether the findings of the present 
study can be generalized.
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